Latest Breaking News On - Life sciences issuer - Page 5 : comparemela.com

Quantum Blockchain Technologies Ltd.: Quantum Announces Conditional Approval of Qualifying Transaction with Ocumetics Technology Corp. and Filing of Filing Statement Quantum ) announces that it has received conditional approval from the TSX Venture Exchange (the Exchange ) for its previously announced proposed amalgamation transaction (the Transaction ) with Ocumetics Technology Corp. ( Ocumetics ), details of which are set forth in Quantum s comprehensive press release dated March 1, 2021. Completion of the Transaction is subject to a number of conditions, including: the completion of a private placement of non-brokered private placement of 21,604,800 common shares at a price of $0.125 per share for total gross proceeds of $2,700,600.00, that holders of not more than 5% of the issued and outstanding shares of Ocumetics shall have exercised rights of dissent in relation to the Amalgamation or to the continuation of Ocumetics into Alberta, approval by the Ocumetics shareho

Kostenloser wertpapierhandelRoger jewettVenture exchange theLife sciences issuerCapital pool corporationExchange requirementsQuantum blockchain technologies ltdVenture exchange incIssuance of the final exchange bulletinAlberta newsfile corpRegulation services providerVenture exchangeOcumetics technology corpBlockchain technologiesOcumetics technologyRestated amalgamation agreement